CTFN's #ICYMI weekend edition: #Merger and deal activity are expected to be robust in 2021, and regulator scrutiny is expected to be rigorous.

(thread) #antitrust #investming #stocks

In the meantime, key changes will occur under the new #Biden administration at the U.S. Federal Trade Commission that is anticipated to weigh heavily on big pharma deals, @dalter28 wrote

#FTC #antitrust #MnA
Further for one big pharma deal, Surani Fernando wrote that while @AstraZeneca's $39 billion bid for @AlexionPharma has drawn a number of critics, a strategic build-out of immunology may prove an important rationale for the deal

#mergers #healthcare $ALXN $AZN
On @Google's acquisition of @Fitbit: the @acccgovau rejected #Google's offer of behavioral remedies this week, though a former ACCC official walked CTFN through how the parties might handle the review

#HeyGoogle #ACCC
The Russian regulatory process for Nova Resources' proposed buyout of Kaz Minerals is unlikely to exceed the standard timeline, CTFN's @CamerinoValeria reported

#shareholders #mergers #mining
Apollo upped the ante and boosted its offer for @GRTCanadian from C$39 to C$45, thus winning shareholder support this week. Negotiations with large shareholders came down to the wire, @dalter28 reported

#mergers #privateequity #casinogames
.@dalter28 also reported on the tussle over the Bristol Myers Squibb CVR trustee. The CVRs are up against a key milestone of December 31 for liso-cel approval.

@bmsnews #BMS #FDA
Make sure to check out CTFN's Daily page for updates on event-driven and #MnA related content, key regulatory information, and sourced tidbits from our editorial, reporting, and analyst staff, curated by our Director of Research @Tyler_Tulenko

#stocks #StocksToWatch #mergers
To discuss anything related to CTFN, our coverage, or how to put our resources to work for you, write to [email protected].

#finance #MnA #antitrust

More from Finance

You May Also Like

Ivor Cummins has been wrong (or lying) almost entirely throughout this pandemic and got paid handsomly for it.

He has been wrong (or lying) so often that it will be nearly impossible for me to track every grift, lie, deceit, manipulation he has pulled. I will use...


... other sources who have been trying to shine on light on this grifter (as I have tried to do, time and again:


Example #1: "Still not seeing Sweden signal versus Denmark really"... There it was (Images attached).
19 to 80 is an over 300% difference.

Tweet: https://t.co/36FnYnsRT9


Example #2 - "Yes, I'm comparing the Noridcs / No, you cannot compare the Nordics."

I wonder why...

Tweets: https://t.co/XLfoX4rpck / https://t.co/vjE1ctLU5x


Example #3 - "I'm only looking at what makes the data fit in my favour" a.k.a moving the goalposts.

Tweets: https://t.co/vcDpTu3qyj / https://t.co/CA3N6hC2Lq
So the cryptocurrency industry has basically two products, one which is relatively benign and doesn't have product market fit, and one which is malignant and does. The industry has a weird superposition of understanding this fact and (strategically?) not understanding it.


The benign product is sovereign programmable money, which is historically a niche interest of folks with a relatively clustered set of beliefs about the state, the literary merit of Snow Crash, and the utility of gold to the modern economy.

This product has narrow appeal and, accordingly, is worth about as much as everything else on a 486 sitting in someone's basement is worth.

The other product is investment scams, which have approximately the best product market fit of anything produced by humans. In no age, in no country, in no city, at no level of sophistication do people consistently say "Actually I would prefer not to get money for nothing."

This product needs the exchanges like they need oxygen, because the value of it is directly tied to having payment rails to move real currency into the ecosystem and some jurisdictional and regulatory legerdemain to stay one step ahead of the banhammer.